Woodline Partners LP Elanco Animal Health Inc Transaction History

Woodline Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$12.93 - $18.45 $7.69 Million - $11 Million	594,979 New	594,979 $8.59 Million
Q4 2023 Feb 14, 2024	SELL	$8.6 - $14.94 $22.5 Million - $39 Million	-2,612,962 Reduced 68.04%	1,227,165 $18.3 Million
Q3 2023 Nov 14, 2023	BUY	$9.81 - $12.62 $30.7 Million - $39.5 Million	3,130,273 Added 440.97%	3,840,127 $43.2 Million
Q2 2023 Aug 14, 2023	BUY	$8.08 - $10.37 $5.74 Million - $7.36 Million	709,854 New	709,854 $7.14 Million
Q3 2021 Nov 15, 2021	SELL	$29.2 - $36.72 $3.98 Million - $5.01 Million	-136,322 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.76 - $35.98 $3.92 Million - $4.9 Million	136,322 New	136,322 $4.73 Million
Q1 2021 May 17, 2021	SELL	$27.85 - $34.49 $10.7 Million - $13.2 Million	-383,325 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.53 - $33.79 $10.6 Million - $13 Million	383,325 New	383,325 $11.8 Million

438

473M

4.07M

689K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.66B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

Stay updated on Woodline Partners LP with notifications on news.